Stock BALAXI BALAXI PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

All News Balaxi Pharmaceuticals Limited

Equities

BALAXI

INE618N01022

Market Closed - NSE India S.E.
Other stock markets
 05:28:32 07/06/2024 pm IST 		5-day change 1st Jan Change
113.6 INR +6.71% Intraday chart for Balaxi Pharmaceuticals Limited -4.50% +31.43%
29/05 Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024 CI
09/05 Balaxi Pharmaceuticals Limited Appoints Mahesh Inani as the Compliance Officer CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
CI
Balaxi Pharmaceuticals Limited Appoints Mahesh Inani as the Compliance Officer
CI
Balaxi Pharmaceuticals Limited Announces Resignation of Purnima Singh Kamble as Independent Director
CI
Balaxi Pharmaceuticals Limited Announces Resignation of Udayan Shukla as Company Secretary and Compliance Officer
CI
Balaxi Pharmaceuticals Limited Incorporates New Wholly Owned Subsidiary in Chile
CI
Balaxi Pharmaceuticals Limited Announces Update on Company's Pharmaceutical Formulation Plant
CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
CI
Balaxi Pharmaceuticals Limited completed the acquisition of Balaxi Healthcare Ecuador S.A.S.
CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
CI
Balaxi Pharmaceuticals Limited agreed to acquire Balaxi Healthcare Ecuador S.A.S. for $0.04 million.
CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
CI
Balaxi Pharmaceuticals : Certificate under SEBI (Depositories and Participants) Regulations, 2018
PU
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
CI
Balaxi Pharmaceuticals : Press Release
PU
Balaxi Pharmaceuticals : Extra Ordinary Meeting
PU
Balaxi Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2022
CI
Balaxi Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BALAXI Stock
  4. News Balaxi Pharmaceuticals Limited